Adma Biologics Inc

NASDAQ:ADMA   10:07:31 AM EDT
1.26
-0.03 (-2.33%)
Earnings Announcements

Adma Biologics Posts Q3 Loss Per Share Of $0.13

Published: 11/10/2021 21:56 GMT
Adma Biologics Inc (ADMA) - Adma Biologics Reports Record Third Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments.
Q3 Loss per Share $0.13.
Q3 Revenue Rose 101 Percent to $20.7 Million.
Q3 Earnings per Share View $-0.14 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $22.04 Million
Adjusted EPS is expected to be -$0.10

Next Quarter Revenue Guidance is expected to be $24.86 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.